TG Therapeutics, Inc.

NasdaqCM:TGTX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 5.86 B

Share Price

USD 36.90

Avg Daily Volume

2,327,118

Change (1 day)

1.01%

Change (1 year)

84.69%

Change (YTD)

22.59%

TG Therapeutics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 18.88%

TG Therapeutics, Inc. Return on Equity (ROE) is 18.88% for the Trailing 12 Months (TTM) ending March 31, 2025, a -420.05% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

TG Therapeutics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was -5.90%, a -124.63% change year over year.
TG Therapeutics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 23.95%, a -35.44% change year over year.
TG Therapeutics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 37.10%, a -138.67% change year over year.
TG Therapeutics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was -95.94%, a -271.61% change year over year.